Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Adicet Bio, Inc. Director's Dealing 2018

Nov 6, 2018

34412_dirs_2018-11-06_12a54489-7538-4e75-ab81-0d46bbbe4959.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: resTORbio, Inc. (TORC)
CIK: 0001720580
Period of Report: 2018-11-05

Reporting Person: Grissinger Michael (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-11-05 Stock Option (Right to Buy) $11.82 A 28828 Acquired 2028-11-04 Common Stock (28828) Direct

Footnotes

F1: 33% of the shares shall vest on November 5, 2019, with the remainder vesting ratably monthly thereafter for a period of two (2) years.